In briefBMJ 2007; 335 doi: https://doi.org/10.1136/bmj.39349.473785.68 (Published 27 September 2007) Cite this as: BMJ 2007;335:636
US Congress reauthorises FDA for five years: President Bush is expected to sign a bill that raises by 25% the fees paid by drug companies for the Food and Drug Administration to review new drugs. It also sets up a computerised surveillance system for adverse events that uses data from pharmacies and insurance companies. (See BMJ 2007;335:471 doi: 10.1136/bmj.39316.442836.DB.)
HIV vaccine trial is ended: Merck has halted trials of …
Log in using your username and password
Log in through your institution
Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
Sign up for a free trial